Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.450
-0.030 (-2.03%)
At close: Oct 8, 2026, 4:00 PM EDT
1.520
+0.070 (4.83%)
After-hours: Oct 8, 2026, 7:30 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $252.69 million as of October 8, 2026. It is the 19,405th most valuable company in the world and the 3,385th biggest in the United States. Its market cap has increased by 55.63% in one year.
Market Cap
252.69M
Enterprise Value
127.52M
1-Year Change
55.63%
Global Rank
Country Rank
#3,385 United States
Category
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $252.69M, an increase of 236.62%. That is a compound annual growth rate of 24.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 252.69M | -27.83% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 270.20M |
| Bicycle Therapeutics | 263.87M |
| SAB Biotherapeutics | 259.77M |
| Nautilus Biotechnology | 257.69M |
| AC Immune | 256.52M |
| Camp4 Therapeutics | 252.58M |
| Upstream Bio | 252.49M |
| Sutro Biopharma | 248.05M |